In Vitro Antimicrobial Activities of Commercially Available Tea Tree (Melaleuca alternifolia) Essential Oils.
Anti-Infective Agents
/ pharmacology
Biofilms
/ drug effects
Candida glabrata
/ drug effects
Herpesvirus 1, Human
/ drug effects
Melaleuca
/ chemistry
Methicillin-Resistant Staphylococcus aureus
/ drug effects
Microbial Sensitivity Tests
Pseudomonas aeruginosa
/ drug effects
Reactive Oxygen Species
/ metabolism
Tea Tree Oil
/ pharmacology
Terpenes
/ pharmacology
Journal
Current microbiology
ISSN: 1432-0991
Titre abrégé: Curr Microbiol
Pays: United States
ID NLM: 7808448
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
received:
05
02
2018
accepted:
08
11
2018
pubmed:
14
11
2018
medline:
17
5
2019
entrez:
14
11
2018
Statut:
ppublish
Résumé
Melaleuca alternifolia tea tree oil (TTO) is largely used in cutaneous infections. Clinical observations reported antibacterial, antifungal, and antiviral activities, whereas in vitro experiments ascribed most of biological properties to terpinen-4-ol. Since different plant chemotypes and storage conditions result in variations of chemical composition of commercially available TTO, in this study we investigated the antimicrobial activity and the chemical profile of ten commercially available TTO products. The antimicrobial activity was assessed against Candida glabrata, Herpes simplex virus type 1 (HSV-1), methicillin-resistant Staphylococcus aureus (MRSA), and Pseudomonas aeruginosa grown in planktonic mode or biofilms. Only five out of ten TTO batches reported significant antimicrobial activity. The identified TTO products reduced bacterial survival in biofilms, generated oxidative damage in C. glabrata, and diminished HSV-1 infectivity. GC-MS analysis revealed that all the analyzed TTO batches fitted into the terpinen-4-ol chemotype even if we reported great variability in composition of nine major ISO-specified TTO components. Overall, we were not able to ascribe the antimicrobial activity to the content in terpinen-4-ol. We therefore conclude that the antimicrobial activity of TTO results from complex interaction among different components.
Identifiants
pubmed: 30421144
doi: 10.1007/s00284-018-1594-x
pii: 10.1007/s00284-018-1594-x
doi:
Substances chimiques
Anti-Infective Agents
0
Reactive Oxygen Species
0
Terpenes
0
terpinenol-4
562-74-3
Tea Tree Oil
68647-73-4
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
108-116Références
Science. 1999 May 21;284(5418):1318-22
pubmed: 10334980
Biochem Syst Ecol. 2000 Apr 1;28(4):367-382
pubmed: 10725593
J Appl Microbiol. 2000 Jan;88(1):170-5
pubmed: 10735256
J Antimicrob Chemother. 2000 May;45(5):639-43
pubmed: 10797086
Lancet. 2001 Jul 14;358(9276):135-8
pubmed: 11463434
J Appl Microbiol. 2001 Sep;91(3):492-7
pubmed: 11556915
Br J Biomed Sci. 2001;58(3):139-45
pubmed: 11575735
Clin Microbiol Rev. 2002 Apr;15(2):167-93
pubmed: 11932229
Antimicrob Agents Chemother. 2002 Jun;46(6):1914-20
pubmed: 12019108
J Appl Microbiol. 2003;95(4):853-60
pubmed: 12969301
Am J Infect Control. 2004 Dec;32(8):470-85
pubmed: 15573054
Clin Microbiol Rev. 2006 Jan;19(1):50-62
pubmed: 16418522
Can J Infect Dis Med Microbiol. 2008 Mar;19(2):173-84
pubmed: 19352449
Gastroenterology. 2010 May;138(5):1790-801
pubmed: 20102717
J Chem Ecol. 2010 Jun;36(6):652-61
pubmed: 20509043
CJEM. 2013 May;15(3):141-60
pubmed: 23663462
BMC Infect Dis. 2013 May 30;13:252
pubmed: 23721377
J Appl Microbiol. 2013 Oct;115(4):933-42
pubmed: 23789847
Cold Spring Harb Perspect Med. 2014 Aug 01;4(8):null
pubmed: 25085959
Am J Med Sci. 2015 Mar;349(3):269-75
pubmed: 25374398
Proc Inst Mech Eng H. 2014 Oct;228(10):1083-99
pubmed: 25406229
Front Cell Infect Microbiol. 2014 Dec 23;4:178
pubmed: 25566513
Clin Microbiol Infect. 2015 May;21 Suppl 1:S1-25
pubmed: 25596784
J Agric Food Chem. 2015 Mar 18;63(10):2674-82
pubmed: 25727364
Nat Rev Microbiol. 2016 Aug 11;14(9):576-88
pubmed: 27510864
Microbiol Rev. 1995 Jun;59(2):201-22
pubmed: 7603409
Am J Infect Control. 1996 Jun;24(3):186-9
pubmed: 8806995
Lett Appl Microbiol. 1998 Mar;26(3):194-8
pubmed: 9569708